Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique

Methods in Molecular Biology

Volumn 1138, Issue , 2014, Pages 27-39

  de Alwis, Ruklanthi ^a   de Silva, Aravinda M ^a  

^a NONE

Author keywords

Dengue virus; Flow cytometry; Human monocytic cells; Neutralization assay; Serotypes; U937 cells (with DC SIGN); Vero cells

Indexed keywords

NEUTRALIZING ANTIBODY; CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY;

ARTICLE; ASSAY; CELL LINE; DENGUE VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NONHUMAN; PLAQUE REDUCTION NEUTRALIZATION ASSAY; PRIORITY JOURNAL; STAINING; CLASSIFICATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; SERODIAGNOSIS; SEROTYPING; STATISTICS; U937 CELL LINE; VIRUS CULTURE;

DENGUE VIRUS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL ADHESION MOLECULES; DENGUE VIRUS; FLOW CYTOMETRY; HUMANS; LECTINS, C-TYPE; NEUTRALIZATION TESTS; RECEPTORS, CELL SURFACE; SERIAL PASSAGE; SEROTYPING; STAINING AND LABELING; STATISTICS AS TOPIC; U937 CELLS;

EID: 84910130956     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0348-1_3     Document Type: Article

References (15)

1. Murphy BR, Whitehead SS (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29:587–619. doi:10.1146/annurev-immunol-031210-101315
2. Simmons CP, Farrar JJ, Nguyen v V, Wills B (2012) Dengue. N Engl J Med 366(15):1423–1432. doi:10.1056/NEJMra1110265
3. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I (2010) Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcgamma receptor (FcgammaR)-negative and FcgammaR-expressing BHK-21 cells. Clin Vaccine Immunol 17(3):402–407. doi:10.1128/CVI.00396-09
4. Moi ML, Lim CK, Chua KB, Takasaki T, Kurane I (2012) Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcgammaR-expressing cells. PLoS Negl Trop Dis 6(2):e1536. doi:10.1371/journal.pntd.0001536
5. Wu RS, Chan KR, Tan HC, Chow A, Allen JC Jr, Ooi EE (2012) Neutralization of dengue virus inthe presence of Fc receptor-mediated phagocytosis distinguishes serotype-specific from crossneutralizing antibodies. Antiviral Res 96(3): 340–343. doi:10.1016/j.antiviral.2012.09.018
6. Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM (2009) Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392(1):103–113. doi:10.1016/j.virol.2009.06.037
7. Wahala WM, Donaldson EF, de Alwis R, Accavitti-Loper MA, Baric RS, de Silva AM (2010) Natural strain variation and antibody neutralization of dengue serotype 3 viruses. PLoS Pathog 6(3):e1000821. doi:10.1371/journal.ppat.1000821
8. Diamond MS, Harris E, Ennis FA (2012) Defeating dengue: a challenge for a vaccine.Nat Med 18(11):1622–1623. doi:10.1038/nm.2997
9. Kraus AA, Messer W, Haymore LB, de Silva AM (2007) Comparison of plaque- and flow cytometry- based methods for measuring dengue virus neutralization. J Clin Microbiol 45(11):3777– 3780. doi:10.1128/JCM.00827-07
10. Navarro-Sanchez E, Altmeyer R, Amara A, Schwartz O, Fieschi F, Virelizier JL, Arenzana-Seisdedos F, Despres P (2003) Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4(7):723–728. doi:10.1038/sj.embor.embor866
11. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM, Malasit P, Despres P, Julier C (2005) A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37(5):507–513. doi:10.1038/ng1550
12. Zompi S, Santich BH, Beatty PR, Harris E (2011) Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol 188(1):404–416. doi:jimmunol.1102124, [pii]10.4049/jimmunol.1102124
13. Yokoyama WM, Christensen M, Santos GD, Miller D (2006) Production of monoclonal antibodies. Curr Protoc Immunol Chapter 2:Unit 2 5. doi:10.1002/0471142735.im0205s74
14. Henchal EA, Gentry MK, McCown JM, Brandt WE (1982) Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 31(4):830–836
15. Kaufman BM, Summers PL, Dubois DR, Cohen WH, Gentry MK, Timchak RL, Burke DS, Eckels KH (1989) Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 41(5):576–580